Displaying 1 - 11 of 11

Display:

12 24 48

Liver Tumours

6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View

Liver Tumours

6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View

Liver Tumours

6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View

Liver Tumours

6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View

Liver Tumours

6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View

Liver Tumours

6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View

Liver Tumours

5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View

Liver Tumours

5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View

Liver Tumours

5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View

Liver Tumours

5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View

Liver Tumours

5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View

Displaying 1 - 11 of 11

Display:

12 24 48